334 related articles for article (PubMed ID: 21925552)
1. Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.
Grant-Klein RJ; Altamura LA; Schmaljohn CS
Virus Res; 2011 Dec; 162(1-2):148-61. PubMed ID: 21925552
[TBL] [Abstract][Full Text] [Related]
2. Progress in filovirus vaccine development: evaluating the potential for clinical use.
Falzarano D; Geisbert TW; Feldmann H
Expert Rev Vaccines; 2011 Jan; 10(1):63-77. PubMed ID: 21162622
[TBL] [Abstract][Full Text] [Related]
3. Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses.
Marzi A; Feldmann F; Geisbert TW; Feldmann H; Safronetz D
Emerg Infect Dis; 2015 Feb; 21(2):305-7. PubMed ID: 25625358
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.
Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS
Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccines for biodefense.
Dupuy LC; Schmaljohn CS
Expert Rev Vaccines; 2009 Dec; 8(12):1739-54. PubMed ID: 19943766
[TBL] [Abstract][Full Text] [Related]
6. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
[TBL] [Abstract][Full Text] [Related]
7. A single shot against Ebola and Marburg virus.
Baize S
Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
[No Abstract] [Full Text] [Related]
8. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
Pushko P; Geisbert J; Parker M; Jahrling P; Smith J
J Virol; 2001 Dec; 75(23):11677-85. PubMed ID: 11689649
[TBL] [Abstract][Full Text] [Related]
9. Prospects for immunisation against Marburg and Ebola viruses.
Geisbert TW; Bausch DG; Feldmann H
Rev Med Virol; 2010 Nov; 20(6):344-57. PubMed ID: 20658513
[TBL] [Abstract][Full Text] [Related]
10. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
11. Vaccine research efforts for filoviruses.
Hart MK
Int J Parasitol; 2003 May; 33(5-6):583-95. PubMed ID: 12782057
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
Front Immunol; 2021; 12():703986. PubMed ID: 34484200
[TBL] [Abstract][Full Text] [Related]
13. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
Suschak JJ; Schmaljohn CS
Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
[TBL] [Abstract][Full Text] [Related]
14. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
Jones SM; Feldmann H; Ströher U; Geisbert JB; Fernando L; Grolla A; Klenk HD; Sullivan NJ; Volchkov VE; Fritz EA; Daddario KM; Hensley LE; Jahrling PB; Geisbert TW
Nat Med; 2005 Jul; 11(7):786-90. PubMed ID: 15937495
[TBL] [Abstract][Full Text] [Related]
15. Ebola and Marburg virus vaccines.
Reynolds P; Marzi A
Virus Genes; 2017 Aug; 53(4):501-515. PubMed ID: 28447193
[TBL] [Abstract][Full Text] [Related]
16. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
Leroy E; Baize S; Gonzalez JP
Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
[TBL] [Abstract][Full Text] [Related]
17. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
Geisbert TW; Feldmann H
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
[TBL] [Abstract][Full Text] [Related]
18. Marburg and Ebola--arming ourselves against the deadly filoviruses.
Peters CJ
N Engl J Med; 2005 Jun; 352(25):2571-3. PubMed ID: 15972860
[No Abstract] [Full Text] [Related]
19. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
Swenson DL; Wang D; Luo M; Warfield KL; Woraratanadharm J; Holman DH; Dong JY; Pratt WD
Clin Vaccine Immunol; 2008 Mar; 15(3):460-7. PubMed ID: 18216185
[TBL] [Abstract][Full Text] [Related]
20. Development of a preventive vaccine for Ebola virus infection in primates.
Sullivan NJ; Sanchez A; Rollin PE; Yang ZY; Nabel GJ
Nature; 2000 Nov; 408(6812):605-9. PubMed ID: 11117750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
